CoreWeave财报后暴跌近21% 多重因素引发市场担忧

Core Financial Performance - CoreWeave reported an adjusted loss per share of $0.27, exceeding analyst expectations of $0.21 [1] - Revenue reached $1.21 billion, more than tripling year-over-year and surpassing Wall Street's forecast of $1.08 billion [1] - The company raised its revenue guidance for the current quarter to between $1.26 billion and $1.3 billion, above analyst expectations of $1.25 billion [1] - CoreWeave also increased its 2025 revenue forecast to between $5.15 billion and $5.3 billion, up from a previous estimate of $4.9 billion to $5.1 billion, and higher than the market consensus of $5.05 billion [1] Market Reactions and Concerns - Despite positive guidance, the results fell short of heightened market expectations, leading analysts to question the sustainability of the stock's previous gains [1] - CoreWeave's stock has risen over 240% since its IPO in March, but the upcoming end of the IPO lock-up period raises concerns about potential insider selling, which could lead to stock price volatility [1] - Core Scientific's stock dropped by 8.34%, reflecting market uncertainty related to CoreWeave's recent acquisition and potential dilution issues [1] Capital Expenditure and Demand - CoreWeave maintained its full-year capital expenditure guidance at $20 billion to $23 billion, slightly above the market consensus of $21.03 billion, but did not raise its third-quarter guidance from the second quarter [2] - Analysts from Morgan Stanley noted that the delay in capital expenditure could indicate uncertainty in deployment timelines, potentially leading to reduced recognized revenue for the quarter [2] - CoreWeave's CFO stated that customer demand continues to exceed supply capacity, with notable clients including OpenAI, Microsoft, and NVIDIA, and recent expansion agreements with large-scale customers [2] - OpenAI holds shares in CoreWeave and has signed a multi-billion dollar cloud infrastructure supply contract lasting until April 2029 [2]